NCT03401060 2026-03-31
DenosuMast
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
Clinical Trials
59 trialsNCT05016310 2025-07-23
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
Wake Forest University Health Sciences
Phase NA Completed
NCT00963417 2025-07-14
TEXT-Bone
ETOP IBCSG Partners Foundation
Phase NA Completed
NCT04037436 2025-04-13
MoveStrong
University of Waterloo
Phase NA Completed
NCT04663685 2024-05-13
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
University of Waterloo
Phase NA Completed
NCT05970250 2023-08-01
Effect Of Whole Body Vibration Versus Weight Bearing Exercises On Osteoporosis In Breast Cancer Patients After Chemotherapy
Cairo University
Phase NA Completed
NCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT02789800 2022-11-03
PACEinMM-QC
Université de Sherbrooke
Phase NA Completed
NCT03798418 2022-11-01
Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases
Changhua Christian Hospital
Phase NA Completed
NCT03408119 2022-10-07
Dried Plums Prevent Inflammation And Improve Bone Health in Osteopenic Men
Florida State University
Phase NA Completed
NCT02304757 2021-11-17
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Completed
NCT00452439 2020-12-28
A Study of Actonel for the Prevention of Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT04637360 2020-11-19
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
Min-Sheng General Hospital
Phase NA Completed
NCT02455154 2020-04-14
COAT
Shanghai Jiao Tong University School of Medicine
Phase 2 Completed
NCT00354302 2020-04-02
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
Canadian Cancer Trials Group
Phase 3 Completed
NCT00305695 2020-03-24
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
GOG Foundation
Phase 2 Completed
NCT00436917 2019-09-11
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Mayo Clinic
Phase NA Completed
NCT00639210 2019-02-26
BREX
Finnish Breast Cancer Group
Phase 3 Completed
NCT00980174 2018-10-17
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Amgen
Phase 3 Completed
NCT00824993 2018-09-13
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00211211 2017-12-08
FREE Study - Fracture Reduction Evaluation
Medtronic Spinal and Biologics
Phase 4 Completed
NCT00329797 2017-11-29
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00485953 2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4 Completed
NCT00063609 2017-09-13
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Novartis
Phase 4 Completed
NCT00925600 2017-05-30
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Amgen
Phase 3 Completed
NCT00186901 2017-05-10
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
St. Jude Children's Research Hospital
Phase 3 Completed
NCT01871519 2017-03-29
EVOLVE
Medtronic Spinal and Biologics
Phase NA Completed
NCT02484131 2017-03-27
Bone Health Management for Women Diagnosed With Breast Cancer
University of British Columbia
Phase NA Completed
NCT00321932 2017-03-09
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
University of Minnesota
Phase 2 Completed
NCT00172055 2017-03-06
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
Novartis
Phase 3 Completed
NCT00043069 2016-12-07
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00107263 2016-12-06
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00022087 2016-07-19
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00054418 2016-07-13
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01694784 2016-04-19
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
University of North Carolina, Chapel Hill
Phase NA Completed
NCT00000611 2016-04-15
Women's Health Initiative (WHI)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT00580788 2016-02-11
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT00660686 2015-10-21
Exercise for Physical Health in Men With Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00118508 2015-08-13
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
University of Pittsburgh
Phase NA Completed
NCT00050011 2014-03-21
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Novartis
Phase 3 Completed
NCT00049452 2014-01-06
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00129142 2013-11-15
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
GTx
Phase 3 Completed
NCT00859703 2013-10-31
RISAROS
Hospices Civils de Lyon
Phase 3 Completed
NCT00003903 2013-10-16
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
University of Rochester
Phase NA Completed
NCT00114270 2013-03-26
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
National Cancer Institute (NCI)
Phase NA Completed
NCT00301873 2013-02-18
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma
Duke University
Phase 2 Completed
NCT00766532 2012-09-14
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
University of Wisconsin, Madison
Phase 4 Completed
NCT00369850 2012-07-27
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT01250314 2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT00031811 2012-05-28
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
OHSU Knight Cancer Institute
Phase NA Completed